New hope for brittle bones: drug boosts phosphate in rare bone disorder
NCT ID NCT05509595
First seen Feb 02, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tested a drug called burosumab in 12 people with fibrous dysplasia, a condition that weakens bones and often causes low blood phosphate. Participants injected the drug at home once or twice a month for 48 weeks. The main goal was to see if the drug could bring phosphate levels back to a normal range. The study is complete, and results will show whether this approach helps strengthen bones in this rare disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROUS DYSPLASIA OF BONE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.